Fox Run Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-2,925	Closed	-$335K	–	310
2020 Q3	$335K	Sell	2,925 -642	-18%	-$69.3K	0.84%	26
2020 Q2	$400K	Buy	+3,567	New	+$379K	0.53%	41
2020 Q1	–	Sell	-2,344	Closed	-$254K	–	423
2019 Q4	$254K	Sell	2,344 -4,690	-67%	-$502K	0.2%	254
2019 Q3	$689K	Buy	7,034 +2,419	+52%	+$273K	0.63%	9
2019 Q2	$604K	Buy	+4,615	New	+$595K	0.4%	44
2019 Q1	–	Sell	-8,135	Closed	-$792K	–	767
2018 Q4	$792K	Buy	+8,135	New	+$962K	0.42%	25
2018 Q2	–	Sell	-13,562	Closed	-$1.51M	–	993
2018 Q1	$1.51M	Buy	+13,562	New	+$1.62M	0.37%	16
2017 Q4	–	Sell	-8,300	Closed	-$1.16M	–	961
2017 Q3	$1.16M	Buy	8,300 +4,800	+137%	+$652K	0.33%	30
2017 Q2	$426K	Buy	+3,500	New	+$407K	0.15%	280
2016 Q4	–	Sell	-2,600	Closed	-$319K	–	737
2016 Q3	$319K	Buy	+2,600	New	+$335K	0.19%	234